Proton and Photon Radiation Therapy for Retroperitoneal Sarcoma

Proton or Photon RT for Retroperitoneal Sarcomas

Recruiting Phase 1 Phase 2 Interventional Study
Retroperitoneal Sarcoma
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 1/2
Study type
Interventional
Purpose
Treatment
Participants needed
80 (estimated)
Sponsor
Massachusetts General Hospital · Other
Who this trial is looking for

This trial is looking for patients with a specific type of tumor in the abdomen called retroperitoneal sarcoma. Participants will receive a type of radiation therapy before surgery to remove the tumor.

Are You a Good Fit for This Trial?
Rules you out History of a different invasive malignancy within the past 3 yearsHIV positive on combination anti-retroviral therapy

You may be able to join if

  • I have been diagnosed with retroperitoneal sarcoma.
  • I have measurable disease.
  • I expect to live for more than 2 years.

You may not be able to join if

  • I have had prior radiation therapy for retroperitoneal sarcoma.
  • I am pregnant or breastfeeding.
  • I received chemotherapy within 4 weeks before joining the study.
  • I am taking other investigational drugs.
  • I have other types of sarcomas.
  • I have multifocal disease, lymph node, or distant metastases.
  • I have a history of sensitivity to radiation therapy.
  • I have an uncontrolled illness.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
This research study is a Phase I clinical trial. Phase I clinical trials test the safety of an investigational intervention. Phase I studies also try to define the appropriate dose of the investigational therapy to use for further studies. "Investigational" means that the intervention is still being studied and that research doctors are trying to find out more about it. Retroperitoneal sarcomas a…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Histologically proven primary soft tissue sarcoma of the retroperitoneum * Measurable disease * Life expectancy of greater than 2 years Exclusion Criteria: * Prior radiation therapy for retroperitoneal sarcoma * Pregnant or breastfeeding * Chemotherapy within 4 weeks prior t…
Contacts

Thomas DeLaney, MD

617-726-6876

tdelaney@partners.org

CONTACT